Haleon Reports Profit Growth Amid Revenue Decline
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 14 2024
0mins
Source: Business Insider
Haleon plc's stock fell 7.13% and hit a 5-day low amid broader market gains, with the Nasdaq-100 up 1.25% and the S&P 500 up 0.58%.
Despite a revenue decline, Haleon reported a 12.7% increase in fiscal 2025 profit before tax, reaching £2.15 billion. The company's earnings per share rose by 17.8%, reflecting successful cost control and operational efficiency. Additionally, Haleon announced a £500 million share buyback plan for 2026, indicating confidence in future cash flows and a commitment to enhancing shareholder returns.
The profit growth, despite revenue challenges, suggests that Haleon is effectively managing its costs and positioning itself for future growth. The share buyback plan may also support the stock price in the long term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy HLN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on HLN
Wall Street analysts forecast HLN stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 9.210
Low
13.44
Averages
13.44
High
13.44
Current: 9.210
Low
13.44
Averages
13.44
High
13.44
About HLN
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and other. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA) & LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Haleon Launches 'For The Assist' Platform to Support Canadian Soccer
- Brand Partnership Highlight: Haleon's multi-year partnership with Canada Soccer lays the foundation for its 'For The Assist' platform, which aims to enhance brand image by emphasizing everyday health support, thereby increasing consumer recognition and loyalty.
- Athlete Endorsement: The new advertising campaign features Men's National Team player Richie Laryea, highlighting the importance of daily health habits, which aims to leverage athlete influence to boost market penetration and consumer loyalty for Haleon.
- Health Product Promotion: Haleon offers leading brands across six major health categories, such as Advil and Sensodyne, showcasing through the 'For The Assist' platform how its products provide support in everyday life, thus enhancing the brand's competitive position in the market.
- National Promotion Campaign: Through a fully integrated marketing campaign, including online videos, out-of-home advertising, and experiential marketing, Haleon plans to elevate brand awareness nationwide, capitalizing on the cultural energy of sports events to attract more consumer attention to its health products.
See More
Volatility in UK Assets Amid Political Turmoil and Investment Opportunities
- Political Turmoil Impacting Markets: The recent volatility in UK assets, particularly the 10-year gilt yield nearing post-2008 highs, reflects market uncertainty stemming from Prime Minister Keir Starmer's questioned leadership and potential challenges from rival Andy Burnham.
- Investor Optimism on Large Caps: Despite the political upheaval, Citi analysts maintain a bullish outlook on the FTSE 100, citing its significant commodity and defensive exposure as a geopolitical hedge, indicating strong investor confidence in large-cap stocks.
- Opportunities in Small Caps: Jupiter Asset Management's Adrian Gosden highlights that while small and mid-cap stocks (SMIDs) face severe challenges, identifying financially sound companies could yield substantial returns, especially given the current pessimistic market sentiment.
- Attraction of SALO Businesses: Ben Needham from Ninety One notes that the market's harsh treatment of soft asset, low obsolescence SALO businesses has created attractive investment opportunities, particularly as many companies accelerate buybacks and cash returns, signaling strong value amidst the turmoil.
See More
Haleon Appoints New US Chief Marketing Officer
- Executive Appointment: Haleon has announced the appointment of Richard Manso as US Chief Marketing Officer effective April 27, 2026, tasked with driving the company's evolution into a more agile, consumer-centric organization, which is expected to enhance its competitive position in the consumer health sector.
- Market Strategy: Manso will lead Haleon's integrated US marketing team, focusing on enhancing consumer experiences in health decision-making through the integration of data, technology, and human insights, thereby strengthening brand trust and customer loyalty.
- Industry Context: Manso's appointment comes at a significant transformation period in consumer health, where rising consumer expectations for personalized, transparent, and on-demand experiences make marketing increasingly critical in shaping brand identity and customer relationships.
- Future Outlook: Manso's extensive experience at Google will bring a fresh perspective to Haleon, aiding the company in building closer consumer connections in health management and driving future growth, particularly in priority areas such as Medicare Advantage OTC and Women's and Pediatric Health.
See More
NASDAQ 100 Pre-Market Update Highlights Active Stocks
- Pre-Market Indicator Rise: The NASDAQ 100 Pre-Market Indicator increased by 108.49 points to 24,642.07, indicating a positive market sentiment that could set the tone for today's trading.
- Active Stock Performance: Haleon plc (HLN) is trading at $10.06, which is 75.07% of its target price of $13.4, reflecting cautious market sentiment regarding its future performance.
- Nokia Price Recovery: Nokia Corporation (NOK) rose by $0.15 to $8.29, currently exceeding its target price of $7.73 by 107.24%, indicating optimistic market expectations for its prospects.
- Circle Internet Group's Positive Outlook: Circle Internet Group, Inc. (CRCL) increased by $3.89 to $118.07, currently surpassing its target price of $98 by 120.48%, with upward revisions in its EPS forecast for fiscal Q3 2026, suggesting improved earnings expectations.
See More
parodontax Launches New Gum Care Toothpaste and Mouthwash
- Product Innovation: parodontax has launched the new Gum Strengthen & Protect toothpaste and mouthwash, featuring hyaluronic acid to enhance gum protection with continued twice-daily use, helping consumers maintain oral health.
- Ingredient Benefits: The new products leverage hyaluronic acid for improved foaming and freshness, with the toothpaste strengthening the seal between gums and teeth, while the mouthwash effectively kills plaque bacteria along the gumline to support hydration.
- Market Demand: As consumers increasingly prioritize preventative health habits, gum health is becoming a crucial aspect of oral care, with parodontax's research indicating links between gum issues and conditions like heart disease and diabetes.
- Sales Channels: The new products are now available at major retailers including Amazon, Walmart, CVS, and Target, aiming to enhance consumer frequency of use through convenient purchasing options.
See More
Haleon Invests £65M to Expand Oral Health Manufacturing in China
- Market Expansion Plan: Haleon aims to extend its oral health brand parodontax to 30 cities in China by the end of 2027, reaching over 250 million consumers, thereby driving sales growth to meet the rising middle-class demand for trusted international brands.
- New Factory Investment: The company is investing £65 million in a new oral health manufacturing plant in Shanghai, enhancing its local production capabilities to respond more swiftly to consumer preferences and accelerate innovation, supporting its goal of reaching one billion consumers by 2030.
- Product Localization: To resonate with Chinese consumers, Haleon's global R&D team collaborated with local scientists to adapt the flavor and packaging of parodontax, ensuring a blend of clinical efficacy and consumer preferences, thus enhancing market competitiveness.
- Market Opportunity: With China's gum health market valued at approximately £860 million and over 70% of adults experiencing gum issues, Haleon's investment positions it favorably in this rapidly growing market, catering to the demand for clinically proven products.
See More
Haleon Launches 'For The Assist' Platform to Support Canadian Soccer
- Brand Partnership Highlight: Haleon's multi-year partnership with Canada Soccer lays the foundation for its 'For The Assist' platform, which aims to enhance brand image by emphasizing everyday health support, thereby increasing consumer recognition and loyalty.
- Athlete Endorsement: The new advertising campaign features Men's National Team player Richie Laryea, highlighting the importance of daily health habits, which aims to leverage athlete influence to boost market penetration and consumer loyalty for Haleon.
- Health Product Promotion: Haleon offers leading brands across six major health categories, such as Advil and Sensodyne, showcasing through the 'For The Assist' platform how its products provide support in everyday life, thus enhancing the brand's competitive position in the market.
- National Promotion Campaign: Through a fully integrated marketing campaign, including online videos, out-of-home advertising, and experiential marketing, Haleon plans to elevate brand awareness nationwide, capitalizing on the cultural energy of sports events to attract more consumer attention to its health products.
See More
Volatility in UK Assets Amid Political Turmoil and Investment Opportunities
- Political Turmoil Impacting Markets: The recent volatility in UK assets, particularly the 10-year gilt yield nearing post-2008 highs, reflects market uncertainty stemming from Prime Minister Keir Starmer's questioned leadership and potential challenges from rival Andy Burnham.
- Investor Optimism on Large Caps: Despite the political upheaval, Citi analysts maintain a bullish outlook on the FTSE 100, citing its significant commodity and defensive exposure as a geopolitical hedge, indicating strong investor confidence in large-cap stocks.
- Opportunities in Small Caps: Jupiter Asset Management's Adrian Gosden highlights that while small and mid-cap stocks (SMIDs) face severe challenges, identifying financially sound companies could yield substantial returns, especially given the current pessimistic market sentiment.
- Attraction of SALO Businesses: Ben Needham from Ninety One notes that the market's harsh treatment of soft asset, low obsolescence SALO businesses has created attractive investment opportunities, particularly as many companies accelerate buybacks and cash returns, signaling strong value amidst the turmoil.
See More
Haleon Appoints New US Chief Marketing Officer
- Executive Appointment: Haleon has announced the appointment of Richard Manso as US Chief Marketing Officer effective April 27, 2026, tasked with driving the company's evolution into a more agile, consumer-centric organization, which is expected to enhance its competitive position in the consumer health sector.
- Market Strategy: Manso will lead Haleon's integrated US marketing team, focusing on enhancing consumer experiences in health decision-making through the integration of data, technology, and human insights, thereby strengthening brand trust and customer loyalty.
- Industry Context: Manso's appointment comes at a significant transformation period in consumer health, where rising consumer expectations for personalized, transparent, and on-demand experiences make marketing increasingly critical in shaping brand identity and customer relationships.
- Future Outlook: Manso's extensive experience at Google will bring a fresh perspective to Haleon, aiding the company in building closer consumer connections in health management and driving future growth, particularly in priority areas such as Medicare Advantage OTC and Women's and Pediatric Health.
See More
NASDAQ 100 Pre-Market Update Highlights Active Stocks
- Pre-Market Indicator Rise: The NASDAQ 100 Pre-Market Indicator increased by 108.49 points to 24,642.07, indicating a positive market sentiment that could set the tone for today's trading.
- Active Stock Performance: Haleon plc (HLN) is trading at $10.06, which is 75.07% of its target price of $13.4, reflecting cautious market sentiment regarding its future performance.
- Nokia Price Recovery: Nokia Corporation (NOK) rose by $0.15 to $8.29, currently exceeding its target price of $7.73 by 107.24%, indicating optimistic market expectations for its prospects.
- Circle Internet Group's Positive Outlook: Circle Internet Group, Inc. (CRCL) increased by $3.89 to $118.07, currently surpassing its target price of $98 by 120.48%, with upward revisions in its EPS forecast for fiscal Q3 2026, suggesting improved earnings expectations.
See More
parodontax Launches New Gum Care Toothpaste and Mouthwash
- Product Innovation: parodontax has launched the new Gum Strengthen & Protect toothpaste and mouthwash, featuring hyaluronic acid to enhance gum protection with continued twice-daily use, helping consumers maintain oral health.
- Ingredient Benefits: The new products leverage hyaluronic acid for improved foaming and freshness, with the toothpaste strengthening the seal between gums and teeth, while the mouthwash effectively kills plaque bacteria along the gumline to support hydration.
- Market Demand: As consumers increasingly prioritize preventative health habits, gum health is becoming a crucial aspect of oral care, with parodontax's research indicating links between gum issues and conditions like heart disease and diabetes.
- Sales Channels: The new products are now available at major retailers including Amazon, Walmart, CVS, and Target, aiming to enhance consumer frequency of use through convenient purchasing options.
See More
Haleon Invests £65M to Expand Oral Health Manufacturing in China
- Market Expansion Plan: Haleon aims to extend its oral health brand parodontax to 30 cities in China by the end of 2027, reaching over 250 million consumers, thereby driving sales growth to meet the rising middle-class demand for trusted international brands.
- New Factory Investment: The company is investing £65 million in a new oral health manufacturing plant in Shanghai, enhancing its local production capabilities to respond more swiftly to consumer preferences and accelerate innovation, supporting its goal of reaching one billion consumers by 2030.
- Product Localization: To resonate with Chinese consumers, Haleon's global R&D team collaborated with local scientists to adapt the flavor and packaging of parodontax, ensuring a blend of clinical efficacy and consumer preferences, thus enhancing market competitiveness.
- Market Opportunity: With China's gum health market valued at approximately £860 million and over 70% of adults experiencing gum issues, Haleon's investment positions it favorably in this rapidly growing market, catering to the demand for clinically proven products.
See More
